Similarly, in other malignancies (e.g., in breast [35], oesophageal [36], gastric [37] and non-small cell lung cancer [38]), the overexpression of PAI1 is associated with poor prognosis. This evidence concerns the gene SERPINE1 and non-small cell lung carcinoma.